A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants
Clinical trial NCT07421778 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07421778
- Sponsor
- QurAlis Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-02
- Primary completion
- 2026-08-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.